advancing innovation to save lives

Play: TRICK or TREATment?

To enjoy a bit of fun and mischief this Halloween, we’ve created a new game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.
View

More than 150 signatories join GHTC in calling for R&D to be included in GHSA

More than 150 organizations and individuals from around the world have already signed on to GHTC's petition calling for the inclusion of an R&D action package in the 2019-2024 Global Health Security Agenda (GHSA) framework.
Take Action

Member Spotlight: AIDS Vaccine Advocacy Coalition (AVAC)

Founded in 1995, AVAC is a non-profit organization that uses education, policy analysis, advocacy, and a network of global collaborations to accelerate the ethical development and global delivery of AIDS vaccines, male circumcision, microbicides, PrEP, and other emerging HIV prevention options as part of a comprehensive response to the pandemic.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
US budget cuts could jeopardize development of life-saving tools against major killers

Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis and HIV/AIDS, the world’s first malaria vaccine, and other vital global health products in development, according to a new report from GHTC.

Learn More
PATH/Will Boase
PharmExec covers GHTC policy report

PharmExec writes about the release of GHTC's policy report Renewing US leadership: Policies to advance global health research, which warns that US budget cuts could derail development of promising new innovations crucial to fighting leading killers such as HIV/AIDS, tuberculosis, and malaria.

View
View All News & Events

Community Event

Global Health Security 2019
Global Health Security 2019
Australian Government, Indo-Pacific Centre for Health Security, Government of New South Wales, The University of Sydney
Learn More

Community Event

Cenetri Publishing Group
International Conference on Virology, Bacteriology & Infectious Diseases
Infectious Diseases
Learn More
View All Events
Flickr/Craig Fildes
Democrats take the House and Republicans maintain hold on the Senate in midterm elections

While the dust is still settling from the US midterm elections, the major takeaways are set: Democrats have taken the House and Republicans have solidified their hold in the Senate. This means a shake up in leadership and the make-up of key Congressional committees. GHTC takes a look at what these changes could mean for continued US support for global health R&D.

Read More
PATH/Satvir Malhotra
Research Roundup: Chikungunya vaccine trial, Ebola vaccine technology, and Zika biomarkers could lead to prenatal diagnostic

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide